AtaiBeckley Inc. ATAI
$3.94
▲ +3.16% 24H
About
AtaiBeckley Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative psychedelic-based therapeutics and neuroplastogens to treat mental health disorders. The company was formed through the strategic combination of atai Life Sciences and Beckley Psytech Limited in November 2025. AtaiBeckley …
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees54
TickerATAI
Statistics
Market Cap$1.44B
Revenue (TTM)$4.1M
Net Income-$660.0M
Net Margin-16142.0%
EPS$-2.91
P/E-1.32
P/S398.99
P/B6.80
EV/EBITDA-9.57
ROE-378.0%
Dividend Yield—
Price$3.94
Data: Twelve Data · Revenue = mcap / P/S